KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

M Debiec-Rychter; R Sciot; A le Cesne; M Schlemmer; P Hohenberger; AT van Oosterom; JY Blay; S Leyvraz; M Stul; PG Casali; J Zalcberg; Jaap Verweij; M Glabbeke; A Hagemeijer; I Judson

doi:10.1016/j.ejca.2006.01.030

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

M Debiec-Rychter, R Sciot, A le Cesne, M Schlemmer, P Hohenberger, AT van Oosterom, JY Blay, S Leyvraz, M Stul, PG Casali, J Zalcberg, Jaap Verweij, M Glabbeke, A Hagemeijer, I Judson

Research output: Contribution to journal › Article › Academic › peer-review

804 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1093-1103
Number of pages	11
Journal	European Journal of Cancer
Volume	42
Issue number	8
DOIs	https://doi.org/10.1016/j.ejca.2006.01.030
Publication status	Published - 2006
Externally published	Yes

Research programs

EMC MM-03-86-08

Access to Document

10.1016/j.ejca.2006.01.030

http://hdl.handle.net/1765/68869

Cite this

Debiec-Rychter, M., Sciot, R., le Cesne, A., Schlemmer, M., Hohenberger, P., van Oosterom, AT., Blay, JY., Leyvraz, S., Stul, M., Casali, PG., Zalcberg, J., Verweij, J., Glabbeke, M., Hagemeijer, A., & Judson, I. (2006). KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. European Journal of Cancer, 42(8), 1093-1103. https://doi.org/10.1016/j.ejca.2006.01.030

@article{87b5bbd81cc74351bf74cbf577c73cd0,

title = "KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours",

author = "M Debiec-Rychter and R Sciot and {le Cesne}, A and M Schlemmer and P Hohenberger and {van Oosterom}, AT and JY Blay and S Leyvraz and M Stul and PG Casali and J Zalcberg and Jaap Verweij and M Glabbeke and A Hagemeijer and I Judson",

year = "2006",

doi = "10.1016/j.ejca.2006.01.030",

language = "Undefined/Unknown",

volume = "42",

pages = "1093--1103",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "8",

}

Debiec-Rychter, M, Sciot, R, le Cesne, A, Schlemmer, M, Hohenberger, P, van Oosterom, AT, Blay, JY, Leyvraz, S, Stul, M, Casali, PG, Zalcberg, J, Verweij, J, Glabbeke, M, Hagemeijer, A & Judson, I 2006, 'KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours', European Journal of Cancer, vol. 42, no. 8, pp. 1093-1103. https://doi.org/10.1016/j.ejca.2006.01.030

TY - JOUR

T1 - KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

AU - Debiec-Rychter, M

AU - Sciot, R

AU - le Cesne, A

AU - Schlemmer, M

AU - Hohenberger, P

AU - van Oosterom, AT

AU - Blay, JY

AU - Leyvraz, S

AU - Stul, M

AU - Casali, PG

AU - Zalcberg, J

AU - Verweij, Jaap

AU - Glabbeke, M

AU - Hagemeijer, A

AU - Judson, I

PY - 2006

Y1 - 2006

U2 - 10.1016/j.ejca.2006.01.030

DO - 10.1016/j.ejca.2006.01.030

M3 - Article

C2 - 16624552

SN - 0959-8049

VL - 42

SP - 1093

EP - 1103

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 8

ER -